Cerner (NASDAQ:CERN) Rating Reiterated by KeyCorp
KeyCorp reiterated their overweight rating on shares of Cerner (NASDAQ:CERN) in a report released on Friday morning, 24/7 WallStreet reports. They currently have a $82.00 target price on the stock, up from their previous target price of $76.00.
A number of other research analysts also recently issued reports on the stock. ValuEngine upgraded shares of Cerner from a hold rating to a buy rating in a research note on Wednesday, May 1st. Citigroup lifted their price target on shares of Cerner from $77.00 to $84.00 and gave the stock a buy rating in a research note on Thursday, July 25th. BidaskClub downgraded shares of Cerner from a hold rating to a sell rating in a research note on Thursday, July 25th. Zacks Investment Research downgraded shares of Cerner from a buy rating to a hold rating and set a $77.00 price target for the company. in a research note on Monday, July 29th. Finally, Wells Fargo & Co lifted their price target on shares of Cerner from $72.00 to $80.00 and gave the stock an outperform rating in a research note on Thursday, July 25th. Two analysts have rated the stock with a sell rating, three have issued a hold rating and eleven have given a buy rating to the company’s stock. Cerner has a consensus rating of Buy and a consensus target price of $73.79.
Shares of CERN stock opened at $71.83 on Friday. The company has a debt-to-equity ratio of 0.22, a quick ratio of 2.50 and a current ratio of 2.52. The stock has a market capitalization of $22.87 billion, a P/E ratio of 32.50, a price-to-earnings-growth ratio of 1.98 and a beta of 0.92. The company has a 50 day moving average price of $72.84 and a 200 day moving average price of $65.65. Cerner has a fifty-two week low of $48.78 and a fifty-two week high of $76.47.
The business also recently disclosed a special dividend, which was paid on Friday, July 26th. Stockholders of record on Tuesday, June 18th were given a dividend of $0.18 per share. The ex-dividend date was Monday, June 17th. Cerner’s dividend payout ratio is presently 32.58%.
In other news, Director William D. Zollars sold 1,400 shares of the business’s stock in a transaction that occurred on Wednesday, June 12th. The shares were sold at an average price of $72.11, for a total transaction of $100,954.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Linda M. Dillman sold 4,100 shares of the business’s stock in a transaction that occurred on Thursday, May 30th. The stock was sold at an average price of $70.14, for a total transaction of $287,574.00. The disclosure for this sale can be found here. Insiders have sold a total of 289,500 shares of company stock valued at $20,225,008 in the last 90 days. Insiders own 0.75% of the company’s stock.
Several large investors have recently modified their holdings of CERN. Nelson Roberts Investment Advisors LLC purchased a new stake in shares of Cerner during the 1st quarter worth approximately $25,000. Berman Capital Advisors LLC lifted its position in shares of Cerner by 115.3% during the 2nd quarter. Berman Capital Advisors LLC now owns 381 shares of the company’s stock worth $27,000 after buying an additional 204 shares during the last quarter. Advisory Alpha LLC purchased a new stake in shares of Cerner during the 1st quarter worth approximately $28,000. Altshuler Shaham Ltd lifted its position in shares of Cerner by 173.2% during the 2nd quarter. Altshuler Shaham Ltd now owns 388 shares of the company’s stock worth $28,000 after buying an additional 246 shares during the last quarter. Finally, Creative Financial Designs Inc. ADV lifted its position in shares of Cerner by 303.4% during the 1st quarter. Creative Financial Designs Inc. ADV now owns 710 shares of the company’s stock worth $41,000 after buying an additional 534 shares during the last quarter. Institutional investors and hedge funds own 81.87% of the company’s stock.
Cerner Corporation provides health care information technology solutions and tech-enabled services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers.
Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.